CoreWeave (CRWV) officer logs trust share sales and holdings in Form 4

Q: Who is the reporting person in the CoreWeave (CRWV) Form 4?

The reporting person is McBee Brannin , who serves as Chief Development Officer of CoreWeave, Inc.

Q: What key share conversion was reported by CoreWeave (CRWV)?

The filing reports that the Canis Minor 2025 GRAT converted 8,335 shares of Class B Common Stock into Class A Common Stock on January 12, 2026 .

Q: Which entities sold CoreWeave (CRWV) Class A shares in this Form 4?

Sales of Class A Common Stock were reported for the Canis Minor 2025 GRAT and the Canis Major SM Trust , both disclosed as indirect holdings related to the reporting person.

Q: How are the sale prices for CoreWeave (CRWV) shares disclosed?

For each sale, the Form 4 reports a weighted average price , with footnotes specifying the price ranges within which the individual trades occurred.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

CoreWeave, Inc.’s Chief Development Officer McBee Brannin reported indirect transactions involving family-related entities in the company’s Class A and Class B common stock on January 12, 2026. The Canis Minor 2025 GRAT converted 8,335 shares of Class B common stock into Class A common stock and then sold those Class A shares in multiple trades under a Rule 10b5-1 trading plan at weighted average prices noted in the filing.

Additional small sales of Class A common stock were reported by the Canis Major SM Trust, with each sale disclosed at its own weighted average price. Following these transactions, indirect holdings reported include Class B common stock and corresponding convertible Class A interests held through the Canis Minor 2025 GRAT, Class B common stock held by Brannin’s spouse, and Class A common stock held by the Canis Major SM Trust and by Brannin’s child.

Insider Trade Summary

Net Seller: 8,835 shares ($784,274)

Net Sell 27 txns

Insider McBee Brannin

Role Chief Development Officer

Sold 8,835 shs ($784K)

Type	Security	Shares	Price	Value
Conversion	Class B Common Stock	8,335	$0.00	--
Conversion	Class A Common Stock	8,335	$0.00	--
Sale	Class A Common Stock	47	$78.5281	$4K
Sale	Class A Common Stock	171	$79.5616	$14K
Sale	Class A Common Stock	36	$80.6589	$3K
Sale	Class A Common Stock	36	$81.9422	$3K
Sale	Class A Common Stock	52	$82.7585	$4K
Sale	Class A Common Stock	258	$84.0479	$22K
Sale	Class A Common Stock	80	$85.2986	$7K
Sale	Class A Common Stock	290	$86.3034	$25K
Sale	Class A Common Stock	482	$87.106	$42K
Sale	Class A Common Stock	1,216	$88.2135	$107K
Sale	Class A Common Stock	2,419	$89.077	$215K
Sale	Class A Common Stock	1,727	$90.0498	$156K
Sale	Class A Common Stock	1,414	$91.1696	$129K
Sale	Class A Common Stock	107	$91.7377	$10K
Sale	Class A Common Stock	18	$78.83	$1K
Sale	Class A Common Stock	9	$81.08	$729.72
Sale	Class A Common Stock	19	$84.0853	$2K
Sale	Class A Common Stock	27	$86.1833	$2K
Sale	Class A Common Stock	64	$87.8639	$6K
Sale	Class A Common Stock	148	$88.9064	$13K
Sale	Class A Common Stock	115	$89.8872	$10K
Sale	Class A Common Stock	91	$91.1037	$8K
Sale	Class A Common Stock	9	$91.87	$826.83
holding	Class B Common Stock	--	--	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class B Common Stock — 941,655 shares (Indirect, Canis Minor 2025 GRAT); Class A Common Stock — 8,335 shares (Indirect, Canis Minor 2025 GRAT)

Footnotes (1)

Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.94 to $78.88, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.14 to $80.09, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.21 to $80.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.39 to $82.19, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.51 to $83.10, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.57 to $84.47, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.56, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.60 to $86.59, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.61 to $87.59, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.63 to $88.62, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.63 to $89.62, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.63 to $90.56, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.65 to $91.63, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.66 to $91.85, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.54 to $79.12, inclusive. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.18 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.63 to $86.47, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.38 to $88.29, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.40 to $89.27, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.46 to $90.31, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.58 to $91.33, inclusive. The reported securities are directly held of record by the reporting person's child. The reported securities are directly held by the reporting person's spouse.

Form 4 Insider Transactions: What Each Field Means →

01/14/2026 - 09:04 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McBee Brannin

(Last)

(First)

(Middle)

C/O COREWEAVE, INC.

290 WEST MT. PLEASANT AVENUE, SUITE 4100

(Street)

LIVINGSTON

07039

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	01/12/2026		C		8,335	A	⁽¹⁾	8,335	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		47	D	$78.5281⁽⁴⁾	8,288	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		171	D	$79.5616⁽⁵⁾	8,117	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		36	D	$80.6589⁽⁶⁾	8,081	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		36	D	$81.9422⁽⁷⁾	8,045	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		52	D	$82.7585⁽⁸⁾	7,993	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		258	D	$84.0479⁽⁹⁾	7,735	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		80	D	$85.2986⁽¹⁰⁾	7,655	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		290	D	$86.3034⁽¹¹⁾	7,365	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		482	D	$87.106⁽¹²⁾	6,883	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		1,216	D	$88.2135⁽¹³⁾	5,667	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		2,419	D	$89.077⁽¹⁴⁾	3,248	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		1,727	D	$90.0498⁽¹⁵⁾	1,521	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		1,414	D	$91.1696⁽¹⁶⁾	107	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		107	D	$91.7377⁽¹⁷⁾	0	I	Canis Minor 2025 GRAT⁽²⁾
Class A Common Stock	01/12/2026		S⁽³⁾		18	D	$78.83⁽¹⁸⁾	56,982	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		9	D	$81.08	56,973	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		19	D	$84.0853⁽²⁰⁾	56,954	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		27	D	$86.1833⁽²¹⁾	56,927	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		64	D	$87.8639⁽²²⁾	56,863	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		148	D	$88.9064⁽²³⁾	56,715	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		115	D	$89.8872⁽²⁴⁾	56,600	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		91	D	$91.1037⁽²⁵⁾	56,509	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock	01/12/2026		S⁽³⁾		9	D	$91.87	56,500	I	Canis Major SM Trust⁽¹⁹⁾
Class A Common Stock								1,800	I	See Footnote⁽²⁶⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽¹⁾	01/12/2026		C			8,335	⁽¹⁾	⁽¹⁾	Class A Common Stock	8,335	⁽¹⁾	941,655	I	Canis Minor 2025 GRAT⁽²⁾
Class B Common Stock	⁽¹⁾							⁽¹⁾	⁽¹⁾	Class A Common Stock	2,280,300		2,280,300	I	By Spouse⁽²⁷⁾

Explanation of Responses:

1. Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

2. The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.

3. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.94 to $78.88, inclusive.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.14 to $80.09, inclusive.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.21 to $80.99, inclusive.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.39 to $82.19, inclusive.

8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.51 to $83.10, inclusive.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.57 to $84.47, inclusive.

10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.56, inclusive.

11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.60 to $86.59, inclusive.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.61 to $87.59, inclusive.

13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.63 to $88.62, inclusive.

14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.63 to $89.62, inclusive.

15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.63 to $90.56, inclusive.

16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.65 to $91.63, inclusive.

17. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.66 to $91.85, inclusive.

18. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.54 to $79.12, inclusive.

19. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

20. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.18 inclusive.

21. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.63 to $86.47, inclusive.

22. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.38 to $88.29, inclusive.

23. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.40 to $89.27, inclusive.

24. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.46 to $90.31, inclusive.

25. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.58 to $91.33, inclusive.

26. The reported securities are directly held of record by the reporting person's child.

27. The reported securities are directly held by the reporting person's spouse.

Remarks:

This Form 4 is Part 4 of 4 for this reporting person. Transactions by the reporting person are continued on this Part 4.

	/s/ Nisha Antony, as Attorney-in-Fact	01/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

Who is the reporting person in the CoreWeave (CRWV) Form 4?

The reporting person is McBee Brannin, who serves as Chief Development Officer of CoreWeave, Inc.

Which entities sold CoreWeave (CRWV) Class A shares in this Form 4?

Sales of Class A Common Stock were reported for the Canis Minor 2025 GRAT and the Canis Major SM Trust, both disclosed as indirect holdings related to the reporting person.

Were the CoreWeave (CRWV) stock sales made under a 10b5-1 plan?

Yes. The filing states that the reported transactions by the Canis Minor 2025 GRAT were effected pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.

How are the sale prices for CoreWeave (CRWV) shares disclosed?

For each sale, the Form 4 reports a weighted average price, with footnotes specifying the price ranges within which the individual trades occurred.

What other indirect CoreWeave (CRWV) holdings are disclosed?

The filing notes additional indirect holdings of CoreWeave stock by the reporting person’s spouse, the Canis Major SM Trust benefiting a minor child, and shares held of record by the reporting person’s child.